Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A novel allele, HLA-C*15:227, identified when typing COVID-19 patients.

ABSTRACT: HLA-C*15:227 differs from HLA-C*15:02:01:01 by a single nonsynonymous change (368A → G Tyrosine 99 to Cysteine).

SUBMITTER: Cheranev V

PROVIDER: S-EPMC8013338 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

A novel allele, HLA-C*15:227, identified when typing COVID-19 patients.

Cheranev Valery V Loginova Maria M Jankevic Tatjana T Kutyavina Svetlana S Rebrikov Denis D

HLA 20210208 4

HLA-C*15:227 differs from HLA-C*15:02:01:01 by a single nonsynonymous change (368A → G Tyrosine 99 to Cysteine). ...[more]

PMID: 33539638

Similar Datasets

A novel HLA-C*15 allele

Project description:A novel HLA-C*15 allele

| PRJEB55222 | ENA

HLA-B*15 predicts survival in Egyptian patients with COVID-19.

Project description:Genetic differences among individuals could affect the clinical presentations and outcomes of COVID-19. Human Leukocyte Antigens are associated with COVID-19 susceptibility, severity, and prognosis. This study aimed to identify HLA-B and -C genotypes among 69 Egyptian patients with COVID-19 and correlate them with disease outcomes and other clinical and laboratory data. HLA-B and -C typing was performed using Luminex-based HLA typing kits. Forty patients (58%) had severe COVID-19; 55% of these patients died, without reported mortality in the moderate group. The alleles associated with severe COVID-19 were HLA-B*41, -B*42, -C*16, and -C*17, whereas HLA-B*15, -C*7, and -C*12 were significantly associated with protection against mortality. Regression analysis showed that HLA-B*15 was the only allele associated with predicted protection against mortality, where the likelihood of survival increased with HLA-B*15 (P < 0.001). Patient survival was less likely to occur with higher total leukocytic count, ferritin, and creatinine levels. This study provides interesting insights into the association between HLA class I alleles and protection from or severity of COVID-19 through immune response modulation. This is the first study to investigate this relationship in Egyptian patients. More studies are needed to understand how HLA class I alleles interact and affect Cytotoxic T lymphocytes and natural killer cell function.

| S-EPMC8485223 | biostudies-literature

Characterization of the novel HLA-DPB1*1348:01 allele by sequencing-based typing.

Project description:HLA-DPB1*1348:01 differs from HLA-DPB1*14:01:01:01 by one nucleotide substitution in codon 147 in exon 3.

| S-EPMC10100256 | biostudies-literature

Characterization of the novel HLA-A*11:422 allele by sequencing-based typing.

Project description:HLA-A*11:422 differs from HLA-A*11:01:01:01 by one nucleotide substitution in codon 285 in exon 5.

| S-EPMC9804577 | biostudies-literature

Characterization of the novel HLA-DQA1*01:89 allele by sequencing-based typing.

Project description:HLA-DQA1*01:89 differs from HLA-DQA1*01:01:01:01 by one nucleotide substitution in codon -5 in exon 1.

| S-EPMC9804194 | biostudies-literature

Characterization of the novel HLA-DRB3*02:179N allele by sequencing-based typing.

Project description:HLA-DRB3*02:179N differs from DRB3*02:02:01:02 by one nucleotide substitution in codon 98 in exon 3.

| S-EPMC9804616 | biostudies-literature

The novel HLA class I allele, HLA-B*14:110, identified by next-generation sequencing.

Project description:The novel HLA-allele B*14:110, differs from B*14:02:01:01, by one nucleotide substitution, c.T247A in exon 2.

| S-EPMC9796622 | biostudies-literature

Characterization of the novel HLA-DPB1*11:01:06 allele by sequencing-based typing.

Project description:HLA-DPB1*11:01:06 differs from HLA-DPB1*11:01:01:01 by one nucleotide substitution in codon 21 in exon 2.

| S-EPMC10100016 | biostudies-literature

Characterization of the novel HLA-DQA1*02:01:14 allele by sequencing-based typing.

Project description:HLA-DQA1*02:01:14 differs from HLA-DQA1*02:01:01:02 by one nucleotide substitution in codon 105 in exon 3.

| S-EPMC10099613 | biostudies-literature

Characterization of the novel HLA-DQA1*05:05:14 allele by sequencing-based typing.

Project description:HLA-DQA1*05:05:14 differs from HLA-DQA1*05:05:01:04 by one nucleotide substitution in codon -8 in exon 1.

| S-EPMC10098539 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data